The Liver is an Inflammatory Mediator of Pulmonary Arterial Hypertension
Navneet Singh, Jordan Lawson, Ashok Ragavendran, Somanshu Banerjee, Andy Hon, Alejandro Vega, Jason S. Hong, Christopher J. Mullin, Mandy G. Pereira, Allyson Sherman-Roe, Alexander T. Jorrin, Tiffaney Cayton, Gregory A. Fishbein, James R. Klinger, William M. Oldham, , Corey E. Ventetuolo
This study identifies subclinical liver dysfunction clusters in PAH patients and links them to pulmonary vascular resistance and immune signaling changes.
bioRxiv · Oct 3, 2025 · PreprintCell Biology